{"abstract": "The agreements between Gilead Sciences and seven Indian firms seek to provide treatment to those infected in 91 developing nations.", "web_url": "https://www.nytimes.com/2014/09/16/business/international/maker-of-hepatitis-c-drug-strikes-deal-on-generics-for-poor-countries.html", "snippet": "The agreements between Gilead Sciences and seven Indian firms seek to provide treatment to those infected in 91 developing nations.", "lead_paragraph": "NEW DELHI \u2014 The maker of one of the costliest drugs in the world announced on Monday that it had struck deals with seven generic drug makers in India to sell lower-cost versions of the medicine \u2014 a $1,000-a-pill hepatitis C treatment \u2014 in poorer countries.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/09/16/business/16hepatitis-pic2/16hepatitis-pic2-articleLarge.jpg", "height": 472, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/09/16/business/16hepatitis-pic2/16hepatitis-pic2-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 472}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/09/16/business/16hepatitis-pic2/16hepatitis-pic2-jumbo.jpg", "height": 805, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/09/16/business/16hepatitis-pic2/16hepatitis-pic2-superJumbo.jpg", "height": 1610, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/09/16/business/16hepatitis-pic2/16hepatitis-pic2-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/09/16/business/16hepatitis-pic2/16hepatitis-pic2-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/09/16/business/16hepatitis-pic2/16hepatitis-pic2-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Maker of Costly Hepatitis C Drug Sovaldi Strikes Deal on Generics for Poor Countries", "kicker": null, "content_kicker": null, "print_headline": "Deal Struck on Generics of Costly Hepatitis C Drug", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Sovaldi (Drug)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Hepatitis", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Gilead Sciences Inc", "rank": 4, "major": "N"}, {"name": "subject", "value": "Generic Brands and Products", "rank": 5, "major": "N"}, {"name": "subject", "value": "Third World and Developing Countries", "rank": 6, "major": "N"}, {"name": "persons", "value": "Alton, Gregg H", "rank": 7, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 8, "major": "N"}], "pub_date": "2014-09-15T10:25:11+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "subsection_name": "International Business", "byline": {"original": "By Gardiner Harris", "person": [{"firstname": "Gardiner", "middlename": null, "lastname": "Harris", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/ededd042-1904-53f8-b822-5940f7052e27", "word_count": 1228, "uri": "nyt://article/ededd042-1904-53f8-b822-5940f7052e27"}